- Home
- BIYA vs ANVS Comparison
BIYA vs ANVS Comparison
Compare BIYA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIYA
- ANVS
- Stock Information
- Founded
- BIYA 2017
- ANVS 2008
- Country
- BIYA China
- ANVS United States
- Employees
- BIYA N/A
- ANVS N/A
- Industry
- BIYA
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- BIYA
- ANVS Health Care
- Exchange
- BIYA NYSE
- ANVS Nasdaq
- Market Cap
- BIYA 61.6M
- ANVS 24.2M
- IPO Year
- BIYA 2025
- ANVS 2020
- Fundamental
- Price
- BIYA $4.88
- ANVS $2.35
- Analyst Decision
- BIYA
- ANVS Strong Buy
- Analyst Count
- BIYA 0
- ANVS 5
- Target Price
- BIYA N/A
- ANVS $34.75
- AVG Volume (30 Days)
- BIYA 298.0K
- ANVS 434.1K
- Earning Date
- BIYA 05-13-2025
- ANVS 05-13-2025
- Dividend Yield
- BIYA N/A
- ANVS N/A
- EPS Growth
- BIYA N/A
- ANVS N/A
- EPS
- BIYA N/A
- ANVS N/A
- Revenue
- BIYA $12,809,211.00
- ANVS N/A
- Revenue This Year
- BIYA N/A
- ANVS N/A
- Revenue Next Year
- BIYA N/A
- ANVS N/A
- P/E Ratio
- BIYA N/A
- ANVS N/A
- Revenue Growth
- BIYA 10.66
- ANVS N/A
- 52 Week Low
- BIYA $1.21
- ANVS $1.11
- 52 Week High
- BIYA $8.00
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- BIYA N/A
- ANVS 68.59
- Support Level
- BIYA N/A
- ANVS $1.95
- Resistance Level
- BIYA N/A
- ANVS $2.58
- Average True Range (ATR)
- BIYA 0.00
- ANVS 0.22
- MACD
- BIYA 0.00
- ANVS 0.06
- Stochastic Oscillator
- BIYA 0.00
- ANVS 79.09
About BIYA BAIYA INTERNATIONAL GROUP INC
Baiya International Group Inc is a company which operates through its subsidiary Gongwuyuan operates a cloud-based internet platform to provide one-stop crowdsourcing recruitment and SaaS-enabled HR solutions in the flexible employment marketplace. The Company's business is focused around on four primary services which are job matching services, entrusted recruitment services, project outsourcing services and abor dispatching services in the flexible employment market within China, mainly in the core manufacturing regions including the Pearl River Delta and Yangtze River Delta region.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.